FDA Approves Pancreatic Cancer Pill That Doubles Survival

A new daily pill has earned FDA approval after clinical trials showed it doubled survival time for pancreatic cancer patients when combined with chemotherapy.

The drug blocks a mutated protein that drives tumor growth in most pancreatic cancer cases.